Search research articles
Contact Us
Filters
Showing results (1-10 of 138) with videos related to
Page
of 14
Sort By:
Nature Reviews. Cancer
|
January 23, 2010
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner, Richard Grose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2019
Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk
Mitch Dowsett, Nicholas Turner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2019
Reply to J.A. Sparano et al
Mitch Dowsett, Nicholas Turner
BMJ Open Quality
|
June 5, 2018
Improving adherence to hepatitis C screening guidelines
Jane Trinh, Nicholas Turner
The Lancet. Oncology
|
November 1, 2019
Endocrine-based therapy versus chemotherapy in advanced breast cancer
Marie Robert, Nicholas Turner
The Lancet. Oncology
|
January 11, 2024
Developing therapies for triple-negative breast cancer subtypes
Alicia Okines, Nicholas Turner
Cancer Discovery
|
December 7, 2017
Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer
Iñaki Comino-Mendez, Nicholas Turner
Health Affairs (Project Hope)
|
March 5, 2014
The critical link between health care and jails
James S Marks, Nicholas Turner
Methods in Molecular Biology (Clifton, N.J.)
|
August 19, 2021
Generation of High-Affinity Aptamer-MIP Hybrid Nanoparticles
Mark Sullivan, Rachel Hand, Nicholas Turner
Nature Reviews. Cancer
|
October 29, 2004
Hallmarks of 'BRCAness' in sporadic cancers
Nicholas Turner, Andrew Tutt, Alan Ashworth
Page
of 14
Search research articles
Search
Showing results (1-10 of 138) with videos related to
Sort By:
Page
of 14
Nature Reviews. Cancer
|
January 23, 2010
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner, Richard Grose
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2019
Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk
Mitch Dowsett, Nicholas Turner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2019
Reply to J.A. Sparano et al
Mitch Dowsett, Nicholas Turner
BMJ Open Quality
|
June 5, 2018
Improving adherence to hepatitis C screening guidelines
Jane Trinh, Nicholas Turner
The Lancet. Oncology
|
November 1, 2019
Endocrine-based therapy versus chemotherapy in advanced breast cancer
Marie Robert, Nicholas Turner
The Lancet. Oncology
|
January 11, 2024
Developing therapies for triple-negative breast cancer subtypes
Alicia Okines, Nicholas Turner
Cancer Discovery
|
December 7, 2017
Predicting Relapse with Circulating Tumor DNA Analysis in Lung Cancer
Iñaki Comino-Mendez, Nicholas Turner
Health Affairs (Project Hope)
|
March 5, 2014
The critical link between health care and jails
James S Marks, Nicholas Turner
Methods in Molecular Biology (Clifton, N.J.)
|
August 19, 2021
Generation of High-Affinity Aptamer-MIP Hybrid Nanoparticles
Mark Sullivan, Rachel Hand, Nicholas Turner
Nature Reviews. Cancer
|
October 29, 2004
Hallmarks of 'BRCAness' in sporadic cancers
Nicholas Turner, Andrew Tutt, Alan Ashworth
Page
of 14